ClinicalTrials.gov
public full text
Public Domain
MK2461 Phase I/II Study in Patients With Advanced Solid Tumors (MK-2461-002 AM1)(COMPLETED)
The purposes of this phase I portion are; 1) to evaluate the safety and tolerability of MK2461 and 2) to determine the recommended phase 2 dose or doses of MK2461. The purpose of the phase II portion is to evaluate the anti-tumor efficacy of MK2461.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study of NM21-1480 in Adult Patients With Advanced Solid Tumors#1047634
- A Study of MG2512 Injection in Participants With Advanced Solid Tumors#851102
- Treatment of Participants With Advanced and/or Refractory Solid Tumors (MK-5108-001)#831094
- An Open-label Study of SG1827 in Subjects With Advanced Solid Tumors#805062
- A Phase I Study of GC101 TIL in Advanced Solid Tumors#1114852
Record · ID 1113848
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive